0000899243-23-002884.txt : 20230127 0000899243-23-002884.hdr.sgml : 20230127 20230127180726 ACCESSION NUMBER: 0000899243-23-002884 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230125 FILED AS OF DATE: 20230127 DATE AS OF CHANGE: 20230127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pandite Arundathy N. CENTRAL INDEX KEY: 0001827232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39593 FILM NUMBER: 23564662 MAIL ADDRESS: STREET 1: 1018 W 11TH ST., SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Shattuck Labs, Inc. CENTRAL INDEX KEY: 0001680367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812575858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 512-900-4690 MAIL ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-25 0 0001680367 Shattuck Labs, Inc. STTK 0001827232 Pandite Arundathy N. C/O SHATTUCK LABS, INC. 500 W. 5TH STREET, SUITE 1200 AUSTIN TX 78701 0 1 0 0 Chief Medical Officer Common Stock 2023-01-25 4 A 0 37875 0.00 A 175792 D Stock Option (Right to Buy) 3.57 2023-01-25 4 A 0 69750 0.00 A 2033-01-25 Common Stock 69750 69750 D Consists of 37,875 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer. This option represents a right to purchase a total of 69,750 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer. /s/ Erin Ator Thomson, Attorney-in-fact for Arundathy N. Pandite 2023-01-27